EMG and Delta Function in Standard RTSA vs Lateralization
NCT: NCT07464977 · NOT_YET_RECRUITING
Brief Summary
Reverse total shoulder arthroplasty (RTSA) is a well-established method to treat patients with irreparable rotator cuff tears and glenohumeral osteoarthritis. The biomechanical principle implies a medialization and distalization of the center of rotation (COR). Deficiencies in internal and external rotation constitute frequently encountered functional problems. Some studies showed reduced activation of the posterior deltoid in EMG measurements, which may explain the inability to compensate these movements. Lateralized prosthetic designs demonstrated increased external rotation through an alteration of the deltoid's lever arm. The aim of the study is to investigate the impact of lateralization on functional outcome and deltoid EMG activity in comparison to a standard implantation technique.
Frequently Asked Questions
What is EMG and Delta Function in Standard RTSA vs Lateralization?
EMG and Delta Function in Standard RTSA vs Lateralization is a clinical trial registered under NCT07464977. Current status: NOT_YET_RECRUITING.
What is the status of NCT07464977?
The current status of NCT07464977 (EMG and Delta Function in Standard RTSA vs Lateralization) is: NOT_YET_RECRUITING.
When did EMG and Delta Function in Standard RTSA vs Lateralization start?
EMG and Delta Function in Standard RTSA vs Lateralization started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.